TY  - JOUR
AU  - Manzardo, Christian
AU  - Londoño, Maria C
AU  - Castells, LLuis
AU  - Testillano, Milagros
AU  - Luis Montero, Jose
AU  - Peñafiel, Judit
AU  - Subirana, Marta
AU  - Moreno, Ana
AU  - Aguilera, Victoria
AU  - Luisa Gonzalez-Dieguez, Maria
AU  - Calvo-Pulido, Jorge
AU  - Xiol, Xavier
AU  - Salcedo, Magdalena
AU  - Cuervas-Mons, Valentin
AU  - Manuel Sousa, Jose
AU  - Suarez, Francisco
AU  - Serrano, Trinidad
AU  - Ignacio Herrero, Jose
AU  - Jimenez, Miguel
AU  - Fernandez, Jose R
AU  - Gimenez, Carlos
AU  - Del Campo, Santos
AU  - Esteban-Mur, Juan I
AU  - Crespo, Gonzalo
AU  - Moreno, Asuncion
AU  - de la Rosa, Gloria
AU  - Rimola, Antoni
AU  - Miro, Jose M
PY  - 2018
DO  - 10.1111/ajt.14996
UR  - http://hdl.handle.net/10668/12665
T2  - American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
AB  - Direct-acting antivirals have proved to be highly efficacious and safe in monoinfected liver transplant (LT) recipients who experience recurrence of hepatitis C virus (HCV) infection. However, there is a lack of data on effectiveness and tolerability...
LA  - en
PB  - Elsevier
KW  - Clinical research/practice
KW  - Infection and infectious agents-viral
KW  - Human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) 
KW  - Liver transplantation
KW  - Hepatitis C
KW  - Antiviral agents
KW  - Coinfection
KW  - Drug therapy, combination
KW  - Female
KW  - Follow-up studies
KW  - HIV
KW  - HIV infections
KW  - Hepacivirus
KW  - Hepatitis C
KW  - Humans
KW  - Liver transplantation
KW  - Male
KW  - Middle aged
KW  - Prognosis
KW  - Prospective studies
KW  - Recurrence
KW  - Transplant recipients
TI  - Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study.
TY  - research article
VL  - 18
ER  -